ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 232 filers reported holding ACADIA PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.85 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $184 | -15.6% | 8,884 | -23.6% | 0.00% | 0.0% |
| Q1 2023 | $218 | -99.8% | 11,628 | +158.5% | 0.00% | – |
| Q2 2021 | $110,000 | -44.7% | 4,499 | -41.7% | 0.00% | -100.0% |
| Q1 2021 | $199,000 | +22.8% | 7,711 | +154.7% | 0.00% | 0.0% |
| Q4 2020 | $162,000 | +362.9% | 3,028 | +257.1% | 0.00% | – |
| Q3 2020 | $35,000 | -27.1% | 848 | -13.9% | 0.00% | – |
| Q2 2020 | $48,000 | – | 985 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 27,228,338 | $611,821,000 | 5.19% |
| First Washington CORP | 176,950 | $3,976,000 | 2.06% |
| SECTORAL ASSET MANAGEMENT INC | 783,424 | $17,604,000 | 1.93% |
| HARVEY CAPITAL MANAGEMENT INC | 219,042 | $4,921,000 | 1.84% |
| Ghost Tree Capital, LLC | 400,000 | $8,988,000 | 1.82% |
| Opus Point Partners Management, LLC | 36,733 | $825,000 | 1.62% |
| Palo Alto Investors LP | 1,650,780 | $37,093,000 | 1.59% |
| EMORY UNIVERSITY | 84,714 | $1,904,000 | 1.36% |
| GARRISON BRADFORD & ASSOCIATES INC | 69,000 | $1,550,000 | 1.32% |
| HealthCor Management, L.P. | 1,378,000 | $30,964,000 | 1.05% |